Humira(CF) pen 40 MG/0.4 MLS
Ended Awarded Last action
- Contract number
- SPE2DR26F5G0L
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,091
Award facts
- Contract value 100% obligated
- $14,091.23 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $14,091.23 firm fixed-price delivery order to AmerisourceBergen Drug Corp for HUMIRA (Adalimumab) CF Pen 40 mg/0.4 mL pharmaceutical supplies on January 29, 2026, with completion scheduled for January 30, 2026. This is a non-set-aside competitive award with performance at the contractor's facility in Conshohocken, Pennsylvania. The delivery order was issued under AmerisourceBergen's parent company, Cencora, Inc., which holds a substantial Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 31, 2031, serving as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen operates as a critical pharmaceutical distributor within the federal supply chain, delivering a comprehensive range of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to military treatment facilities and other government healthcare systems. This particular delivery order for HUMIRA, a rheumatoid arthritis and immunosuppressive disorder treatment, reflects the contractor's consistent role in fulfilling federal medical procurement requirements through the DLA's pharmaceutical support infrastructure. The non-competitive nature of this delivery order, issued under an existing IDC, demonstrates the established vendor relationship and capability to meet urgent military healthcare demands efficiently.
Quick answers
Who was awarded contract SPE2DR26F5G0L?
SPE2DR26F5G0L was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26F5G0L worth?
The government has obligated $14,091 on SPE2DR26F5G0L.
Is contract SPE2DR26F5G0L an order under another contract?
Yes. SPE2DR26F5G0L is a delivery order under SPE2DR25D3306, an indefinite delivery contract.
Was contract SPE2DR26F5G0L competed?
The extent of competition for SPE2DR26F5G0L was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award